BioMed Research International / 2020 / Article / Fig 2

Clinical Study

Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19

Figure 2

The distribution of lymphocytes in the healthy control group (HC) and COVID-19 patients at each period in (a) the glucocorticoid group and (b) the nonglucocorticoid group. The distribution of CD3+ T cells in the healthy control group (HC) and COVID-19 patients at each period in (c) the glucocorticoid group and (d) the nonglucocorticoid group. The distribution of CD4+ T cells in the healthy control group (HC) and COVID-19 patients at each period in (e) the glucocorticoid group and (f) the nonglucocorticoid group. The distribution of CD8+ T cells in the healthy control group (HC) and COVID-19 patients at each period in (g) the glucocorticoid group and (h) the nonglucocorticoid group.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.